• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用全定量纤维化评估工具分析不同病因所致肝纤维化的特征

Characteristics of liver fibrosis with different etiologies using a fully quantitative fibrosis assessment tool.

作者信息

Wu Q, Zhao X, You H

机构信息

Beijing Key Laboratory of Translational Medicine in Liver Cirrhosis, Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

National Clinical Research Center for Digestive Diseases, Beijing, China.

出版信息

Braz J Med Biol Res. 2017 May 18;50(6):e5234. doi: 10.1590/1414-431X20175234.

DOI:10.1590/1414-431X20175234
PMID:28538834
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5479381/
Abstract

This study aimed to test the diagnostic performance of a fully quantitative fibrosis assessment tool for liver fibrosis in patients with chronic hepatitis B (CHB), primary biliary cirrhosis (PBC) and non-alcoholic steatohepatitis (NASH). A total of 117 patients with liver fibrosis were included in this study, including 50 patients with CHB, 49 patients with PBC and 18 patients with NASH. All patients underwent liver biopsy (LB). Fibrosis stages were assessed by two experienced pathologists. Histopathological images of LB slices were processed by second harmonic generation (SHG)/two-photon excited fluorescence (TPEF) microscopy without staining, a system called qFibrosis (quantitative fibrosis) system. Altogether 101 quantitative features of the SHG/TPEF images were acquired. The parameters of aggregated collagen in portal, septal and fibrillar areas increased significantly with stages of liver fibrosis in PBC and CHB (P<0.05), but the same was not found for parameters of distributed collagen (P>0.05). There was a significant correlation between parameters of aggregated collagen in portal, septal and fibrillar areas and stages of liver fibrosis from CHB and PBC (P<0.05), but no correlation was found between the distributed collagen parameters and the stages of liver fibrosis from those patients (P>0.05). There was no significant correlation between NASH parameters and stages of fibrosis (P>0.05). For CHB and PBC patients, the highest correlation was between septal parameters and fibrosis stages, the second highest was between portal parameters and fibrosis stages and the lowest correlation was between fibrillar parameters and fibrosis stages. The correlation between the septal parameters of the PBC and stages is significantly higher than the parameters of the other two areas (P<0.05). The qFibrosis candidate parameters based on CHB were also applicable for quantitative analysis of liver fibrosis in PBC patients. Different parameters should be selected for liver fibrosis assessment in different stages of PBC compared with CHB.

摘要

本研究旨在测试一种用于慢性乙型肝炎(CHB)、原发性胆汁性肝硬化(PBC)和非酒精性脂肪性肝炎(NASH)患者肝纤维化的全定量纤维化评估工具的诊断性能。本研究共纳入117例肝纤维化患者,其中CHB患者50例,PBC患者49例,NASH患者18例。所有患者均接受了肝活检(LB)。由两位经验丰富的病理学家评估纤维化分期。肝活检切片的组织病理学图像通过二次谐波产生(SHG)/双光子激发荧光(TPEF)显微镜在未染色的情况下进行处理,该系统称为qFibrosis(定量纤维化)系统。共获取了101个SHG/TPEF图像的定量特征。PBC和CHB患者门静脉、间隔和纤维区域聚集性胶原的参数随肝纤维化分期显著增加(P<0.05),但分布性胶原的参数未发现同样的情况(P>0.05)。门静脉、间隔和纤维区域聚集性胶原的参数与CHB和PBC患者的肝纤维化分期之间存在显著相关性(P<0.05),但这些患者的分布性胶原参数与肝纤维化分期之间未发现相关性(P>0.05)。NASH参数与纤维化分期之间无显著相关性(P>0.05)。对于CHB和PBC患者,最高相关性存在于间隔参数与纤维化分期之间,其次是门静脉参数与纤维化分期之间,最低相关性存在于纤维参数与纤维化分期之间。PBC的间隔参数与分期之间的相关性显著高于其他两个区域的参数(P<0.05)。基于CHB的qFibrosis候选参数也适用于PBC患者肝纤维化的定量分析。与CHB相比,PBC不同阶段的肝纤维化评估应选择不同的参数。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8bd/5479381/4611b0fd0957/1414-431X-bjmbr-1414-431X20175234-gf04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8bd/5479381/4a5aff97a53c/1414-431X-bjmbr-1414-431X20175234-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8bd/5479381/492a33307d90/1414-431X-bjmbr-1414-431X20175234-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8bd/5479381/377eadfdee75/1414-431X-bjmbr-1414-431X20175234-gf03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8bd/5479381/4611b0fd0957/1414-431X-bjmbr-1414-431X20175234-gf04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8bd/5479381/4a5aff97a53c/1414-431X-bjmbr-1414-431X20175234-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8bd/5479381/492a33307d90/1414-431X-bjmbr-1414-431X20175234-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8bd/5479381/377eadfdee75/1414-431X-bjmbr-1414-431X20175234-gf03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8bd/5479381/4611b0fd0957/1414-431X-bjmbr-1414-431X20175234-gf04.jpg

相似文献

1
Characteristics of liver fibrosis with different etiologies using a fully quantitative fibrosis assessment tool.使用全定量纤维化评估工具分析不同病因所致肝纤维化的特征
Braz J Med Biol Res. 2017 May 18;50(6):e5234. doi: 10.1590/1414-431X20175234.
2
Quantitative fibrosis parameters highly predict esophageal-gastro varices in primary biliary cirrhosis.定量纤维化参数能高度预测原发性胆汁性肝硬化患者的食管胃静脉曲张。
Eur Rev Med Pharmacol Sci. 2016;20(6):1037-43.
3
SHG/TPEF-based image technology improves liver fibrosis assessment of minimally sized needle biopsies.基于 SHG/TPEF 的成像技术提高了微创针活检的肝纤维化评估。
Hepatol Int. 2019 Jul;13(4):501-509. doi: 10.1007/s12072-019-09955-2. Epub 2019 Jun 11.
4
qFibrosis: a fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients.qFibrosis:一种结合组织学特征的全定量创新方法,用于促进动物模型和慢性乙型肝炎患者的准确纤维化评分。
J Hepatol. 2014 Aug;61(2):260-269. doi: 10.1016/j.jhep.2014.02.015. Epub 2014 Feb 26.
5
Digital pathology with artificial intelligence analyses provides greater insights into treatment-induced fibrosis regression in NASH.借助人工智能分析的数字病理学能更深入地洞察非酒精性脂肪性肝炎(NASH)中治疗引起的纤维化消退情况。
J Hepatol. 2022 Nov;77(5):1399-1409. doi: 10.1016/j.jhep.2022.06.018. Epub 2022 Jun 30.
6
Quantitative assessment of liver fibrosis (qFibrosis) reveals precise outcomes in Ishak "stable" patients on anti-HBV therapy.定量评估肝纤维化(qFibrosis)可揭示接受抗乙型肝炎病毒治疗的 Ishak“稳定”患者的精确结果。
Sci Rep. 2018 Feb 14;8(1):2989. doi: 10.1038/s41598-018-21179-2.
7
Advanced septa size quantitation determines the evaluation of histological fibrosis outcome in chronic hepatitis B patients.高级隔室大小定量可确定慢性乙型肝炎患者组织学纤维化结果的评估。
Mod Pathol. 2018 Oct;31(10):1567-1577. doi: 10.1038/s41379-018-0059-x. Epub 2018 May 21.
8
Collagen co-localized with macrovesicular steatosis better differentiates fibrosis progression in non-alcoholic fatty liver disease mouse models.与大泡性脂肪变性共定位的胶原蛋白能更好地区分非酒精性脂肪性肝病小鼠模型中的纤维化进展。
Front Med (Lausanne). 2023 Jun 2;10:1172058. doi: 10.3389/fmed.2023.1172058. eCollection 2023.
9
Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC.通过瞬时弹性成像评估原发性胆汁性胆管炎(PBC)和原发性硬化性胆管炎(PSC)患者的胆汁纤维化情况。
Hepatology. 2006 May;43(5):1118-24. doi: 10.1002/hep.21151.
10
Automated biphasic morphological assessment of hepatitis B-related liver fibrosis using second harmonic generation microscopy.使用二次谐波产生显微镜对乙型肝炎相关肝纤维化进行自动双相形态学评估。
Sci Rep. 2015 Aug 11;5:12962. doi: 10.1038/srep12962.

本文引用的文献

1
ART and science in using transarterial chemoembolization for retreating patients with hepatocellular carcinoma.经动脉化疗栓塞术用于肝细胞癌复治患者的技术与科学
Hepatobiliary Surg Nutr. 2014 Dec;3(6):415-8. doi: 10.3978/j.issn.2304-3881.2014.07.01.
2
Inflammation-based scores and hepatocellular carcinoma.基于炎症的评分与肝细胞癌
Liver Transpl. 2014 Dec;20(12):1529-30. doi: 10.1002/lt.24017.
3
Embolization of porto-systemic shunt as treatment for recurrent hepatic encephalopathy.经颈静脉肝内门体分流术栓塞术治疗复发性肝性脑病
Ann Hepatol. 2014 Sep-Oct;13(5):555-7.
4
Inflammation-based scores do not predict post-transplant recurrence of hepatocellular carcinoma in patients within Milan criteria.基于炎症的评分无法预测米兰标准内患者肝移植后肝细胞癌的复发情况。
Liver Transpl. 2014 Nov;20(11):1327-35. doi: 10.1002/lt.23969.
5
Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C.非侵入性肝纤维化检测在慢性丙型肝炎患者治疗决策中的成本效益。
Hepatology. 2014 Sep;60(3):832-43. doi: 10.1002/hep.27296. Epub 2014 Jul 29.
6
Is MELD the best prognostic score in acute variceal bleeding? The jury is still out.终末期肝病模型(MELD)评分是急性静脉曲张出血的最佳预后评分吗?尚无定论。
Ann Gastroenterol. 2014;27(3):282-283.
7
Future treatments of cirrhosis.肝硬化的未来治疗方法。
Expert Rev Gastroenterol Hepatol. 2014 Jul;8(5):571-81. doi: 10.1586/17474124.2014.902303. Epub 2014 Jun 9.
8
Letter: Prognostic scores in alcoholic hepatitis--authors' reply.信件:酒精性肝炎的预后评分——作者回复。
Aliment Pharmacol Ther. 2014 Jun;39(11):1341. doi: 10.1111/apt.12757.
9
Cost-effectiveness of upcoming treatments for hepatitis C: we need to get the models right.丙型肝炎未来治疗方法的成本效益:我们需要构建正确的模型。
J Hepatol. 2014 Aug;61(2):453-4. doi: 10.1016/j.jhep.2014.04.022. Epub 2014 Apr 26.
10
Beta-blockers in cirrhosis: therapeutic window or an aspirin for all?肝硬化中的β受体阻滞剂:治疗窗口还是适用于所有人的阿司匹林?
J Hepatol. 2014 Aug;61(2):449-50. doi: 10.1016/j.jhep.2014.03.038. Epub 2014 Apr 24.